PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES

A. Zeidan, V. Divino, M. DeKoven, D. Shah, E. Wang, D. Bey, T. Salimi, R. Epstein

Open source

DOI: 10.1097/01.hs9.0000850544.77658.8d
Published: 2022-06
Container: HemaSphere
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/01.hs9.0000850544.77658.8d,
  title = {PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES},
  author = {A. Zeidan and V. Divino and M. DeKoven and D. Shah and E. Wang and D. Bey and T. Salimi and R. Epstein},
  year = {2022},
  journal = {HemaSphere},
  doi = {10.1097/01.hs9.0000850544.77658.8d},
  url = {https://doi.org/10.1097/01.hs9.0000850544.77658.8d}
}

RIS

TY  - JOUR
TI  - PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES
AU  - A. Zeidan
AU  - V. Divino
AU  - M. DeKoven
AU  - D. Shah
AU  - E. Wang
AU  - D. Bey
AU  - T. Salimi
AU  - R. Epstein
PY  - 2022
JO  - HemaSphere
DO  - 10.1097/01.hs9.0000850544.77658.8d
UR  - https://doi.org/10.1097/01.hs9.0000850544.77658.8d
ER  -

APA

Zeidan, A., Divino, V., DeKoven, M., Shah, D., Wang, E., Bey, D., Salimi, T., & Epstein, R. (2022). PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES. HemaSphere. https://doi.org/10.1097/01.hs9.0000850544.77658.8d

Source records

crossref · retrieved 2026-09-27T07:54:09.578Z